Alliqua BioMedical (NASDAQ: ALQA) develops and manufactures electron-beam cross-linked sheet gels for customers that include manufacturers of medical devices, cosmeceuticals, and other commercial product applications. Alliqua operates a 16,000 square foot GMP manufacturing facility in Langhorne, PA that allows for the development and custom manufacture of a wide variety of hydrogels. Alliqua's ability to meet the varying specifications of customers’ needs, maintain tight tolerances, ensure prompt delivery, and provide superior customer service have made us a leader in the cross-linked hydrogel market.
Latest Financial Results
Sep 30, 2018